Kymata Health CBD Guide
CBC (Cannabichromene)
A minor cannabinoid found in full- and broad-spectrum extracts. Interesting in lab and animal studies, but there are no published human trials of CBC on its own.
Level of human evidence: Preclinical only. Numbers in brackets link to the sources at the end of the page.
What it is
CBC is made from the same precursor (CBGA) as THC and CBD. It shows up in small amounts on most full- and broad-spectrum COAs.
How it works
In lab work CBC acts on TRPA1 and TRPV1 channels rather than strongly on cannabinoid receptors. That is the basis of animal pain and inflammation research, which has not been tested in people.
Human studies
We found no completed human trials of CBC alone. Any product claim about CBC for a health condition rests on animal or cell studies.
Doses used in studies
No studied human dose.
Drug interactions
Unknown in people. Products with CBC almost always contain CBD, so CBD’s interactions apply.[1]
Safety
Unknown in people.
Legal status
From December 11, 2026, federal law counts a finished hemp product as hemp only if the whole container holds no more than 0.4 mg of total THC (including THCA and THC-like cannabinoids). Full-spectrum products usually hold far more than that per bottle, so THC-free (isolate or verified broad-spectrum) products are the safe choice. State rules differ and can be stricter.[2]
Other cannabinoids
Compare brands on lab data: best CBD oils, ranked.